Clinical Trials "Systematically Understated" Dangers of Alli
According to a new analysis of seven clinical trials conducted on Alli – a weight-loss medication – the drug’s potential harms were “systematically understated” when it was first made available. The trials, funded by drug manufacturer Roche in the 1990s, “downplayed the frequency of apparent side effects like diarrhea or incontinence,” according to the report published in POLS Medicine.
Alli, the brand name for orlistat, is linked to:
- Severe lower back pain
- Fatigue and shortness of breath
- Confusion and mood changes
- Blood in the urine
- Diminished ability to urinate
Ironically, this weight loss drug is also linked to weight gain and swelling. The severity and frequency of these complications was largely ignored in the clinical trials funded by the drug’s manufacturer – much to the increased risk of patients.
As with all dangerous medications, when aggressive marketing tactics and blatant disregard for patient safety mix, people get hurt. When people get hurt, drug manufacturers must be held accountable for their greed and negligence. When you need a legal team that is not afraid to hold these powerful companies accountable, our New Hampshire dangerous medication attorneys are here to help. We have decades of combined experience holding these companies accountable and are ready to take your case as far as needed to get you the justice you deserve.